药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Heptabarbital
Tedisamil
The risk or severity of QTc prolongation can be increased when Tedisamil is combined with Lenvatinib.
Heptabarbital
Garenoxacin
The risk or severity of QTc prolongation can be increased when Garenoxacin is combined with Lenvatinib.
Heptabarbital
Technetium Tc-99m ciprofloxacin
The risk or severity of QTc prolongation can be increased when Technetium Tc-99m ciprofloxacin is combined with Lenvatinib.
Heptabarbital
Pracinostat
The risk or severity of QTc prolongation can be increased when Pracinostat is combined with Lenvatinib.
Heptabarbital
Azimilide
The risk or severity of QTc prolongation can be increased when Azimilide is combined with Lenvatinib.
Heptabarbital
Fluspirilene
The risk or severity of QTc prolongation can be increased when Fluspirilene is combined with Lenvatinib.
Heptabarbital
Prenylamine
The risk or severity of QTc prolongation can be increased when Prenylamine is combined with Lenvatinib.
Heptabarbital
Terlipressin
The risk or severity of QTc prolongation can be increased when Terlipressin is combined with Lenvatinib.
Heptabarbital
Aceprometazine
The risk or severity of QTc prolongation can be increased when Aceprometazine is combined with Lenvatinib.
Heptabarbital
Probucol
The risk or severity of QTc prolongation can be increased when Probucol is combined with Lenvatinib.
Heptabarbital
Terodiline
The risk or severity of QTc prolongation can be increased when Lenvatinib is combined with Terodiline.
Heptabarbital
Macimorelin
The risk or severity of QTc prolongation can be increased when Lenvatinib is combined with Macimorelin.
Heptabarbital
Deutetrabenazine
The risk or severity of QTc prolongation can be increased when Lenvatinib is combined with Deutetrabenazine.
Heptabarbital
Glasdegib
The risk or severity of QTc prolongation can be increased when Lenvatinib is combined with Glasdegib.
Heptabarbital
Ribociclib
The risk or severity of QTc prolongation can be increased when Lenvatinib is combined with Ribociclib.
Heptabarbital
Lumefantrine
The risk or severity of QTc prolongation can be increased when Lenvatinib is combined with Lumefantrine.
Heptabarbital
Artemether
The risk or severity of QTc prolongation can be increased when Lenvatinib is combined with Artemether.
Heptabarbital
Asenapine
The risk or severity of QTc prolongation can be increased when Lenvatinib is combined with Asenapine.
Heptabarbital
Tetrabenazine
The risk or severity of QTc prolongation can be increased when Lenvatinib is combined with Tetrabenazine.
Heptabarbital
Zuclopenthixol
The risk or severity of QTc prolongation can be increased when Lenvatinib is combined with Zuclopenthixol.